Total Clarity Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-74
| Closed | -$4K | – | 361 |
|
|
2022
Q2 | $4K | Buy |
+74
| New | +$4K | ﹤0.01% | 837 |
|
|
2022
Q1 | – | Sell |
-360
| Closed | -$27K | – | 347 |
|
|
2021
Q4 | $27K | Sell |
360
-150
| -29% | -$11.3K | 0.01% | 508 |
|
|
2021
Q3 | $57K | Buy |
+510
| New | +$57K | 0.03% | 381 |
|
|
2021
Q2 | – | Sell |
-260
| Closed | -$32K | – | 298 |
|
|
2021
Q1 | $32K | Buy |
+260
| New | +$32K | 0.02% | 387 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$6K | – | 191 |
|
|
2019
Q4 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 556 |
|